文献速递围术期管理与 ERAS急腹症与外科感染

美国成人小型和大型手术后新发持续性阿片类药物使用

New Persistent Opioid Use After Minor and Major Surgical Procedures in US Adults.
PubMed 文献 · JAMA Surg · 2017-06-21

结果显示小型和大型手术后的新发持续使用率相似(5.9%-6.5%),远高于非手术对照组的0.4%,且风险因素包括术前吸烟、酒精/药物滥用、情绪障碍、焦虑和疼痛疾病。

要点

  • 小型和大型手术后新发持续性阿片使用率相似(5.9%-6.5%)。
  • 非手术对照组发生率仅0.4%,手术患者风险显著升高。
  • 术前吸烟、物质滥用、情绪障碍、焦虑和疼痛疾病是独立风险因素。

核心结论

  • 术后新发持续性阿片使用常见,且小型与大型手术间无显著差异,而与行为及疼痛障碍相关。

主要发现

  • 新发持续性阿片使用率两组相似,范围为5.9%至6.5%;非手术对照组为0.4%。
  • 独立风险因素包括术前吸烟(aOR 1.35;95%CI 1.21-1.49)、酒精和物质滥用障碍(aOR 1.34;95%CI 1.05-1.72)、情绪障碍(aOR 1.15;95%CI 1.01-1.30)、焦虑(aOR 1.25;95%CI 1.10-1.42)、背痛(aOR 1.57;95%CI 1.42-1.75)、颈痛(aOR 1.22;95%CI 1.07-1.39)、关节炎(aOR 1.56;95%CI 1.40-1.73)和中枢性疼痛(aOR 1.39;95%CI 1.26-1.54)。

临床怎么用

  • 术后应关注患者术前吸烟、物质滥用、情绪障碍、焦虑及疼痛疾病等风险因素,以识别持续性阿片使用高危人群。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

IMPORTANCE: Despite increased focus on reducing opioid prescribing for long-term pain, little is known regarding the incidence and risk factors for persistent opioid use after surgery. OBJECTIVE: To determine the incidence of new persistent opioid use after minor and major surgical procedures. DESIGN, SETTING, AND PARTICIPANTS: Using a nationwide insurance claims data set from 2013 to 2014, we identified US adults aged 18 to 64 years without opioid use in the year prior to surgery (ie, no opioid prescription fulfillments from 12 months to 1 month prior to the procedure). For patients filling a perioperative opioid prescription, we calculated the incidence of persistent opioid use for more than 90 days among opioid-naive patients after both minor surgical procedures (ie, varicose vein removal, laparoscopic cholecystectomy, laparoscopic appendectomy, hemorrhoidectomy, thyroidectomy, transurethral prostate surgery, parathyroidectomy, and carpal tunnel) and major surgical procedures (ie, ventral incisional hernia repair, colectomy, reflux surgery, bariatric surgery, and hysterectomy). We then assessed data for patient-level predictors of persistent opioid use. MAIN OUTCOMES AND MEASURES: The primary outcome was defined a priori prior to data extraction. The primary outcome was new persistent opioid use, which was defined as an opioid prescription fulfillment between 90 and 180 days after the surgical procedure. RESULTS: A total of 36 177 patients met the inclusion criteria, with 29 068 (80.3%) receiving minor surgical procedures and 7109 (19.7%) receiving major procedures. The cohort had a mean (SD) age of 44.6 (11.9) years and was predominately female (23 913 [66.1%]) and white (26 091 [72.1%]). The rates of new persistent opioid use were similar between the 2 groups, ranging from 5.9% to 6.5%. By comparison, the incidence in the nonoperative control cohort was only 0.4%. Risk factors independently associated with new persistent opioid use included preoperative tobacco use (adjusted odds ratio [aOR], 1.35; 95% CI, 1.21-1.49), alcohol and substance abuse disorders (aOR, 1.34; 95% CI, 1.05-1.72), mood disorders (aOR, 1.15; 95% CI, 1.01-1.30), anxiety (aOR, 1.25; 95% CI, 1.10-1.42), and preoperative pain disorders (back pain: aOR, 1.57; 95% CI, 1.42-1.75; neck pain: aOR, 1.22; 95% CI, 1.07-1.39; arthritis: aOR, 1.56; 95% CI, 1.40-1.73; and centralized pain: aOR, 1.39; 95% CI, 1.26-1.54). CONCLUSIONS AND RELEVANCE: New persistent opioid use after surgery is common and is not significantly different between minor and major surgical procedures but rather associated with behavioral and pain disorders. This suggests its use is not due to surgical pain but addressable patient-level predictors. New persistent opioid use represents a common but previously underappreciated surgical complication that warrants increased awareness.

来源:JAMA Surg,查看原文。版权归原作者所有。

引用

  1. Brummett CM, Waljee JF, Goesling J, et al. New Persistent Opioid Use After Minor and Major Surgical Procedures in US Adults. JAMA Surg. 2017. PMID: 28403427. doi:10.1001/jamasurg.2017.0504

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。